PMID- 33282769 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240330 IS - 2231-0762 (Print) IS - 2250-1002 (Electronic) IS - 2231-0762 (Linking) VI - 10 IP - 5 DP - 2020 Sep-Oct TI - The Knowledge and Perception of Antiplatelet and Anticoagulant agents among Dentists in Northern Jordan. PG - 597-604 LID - 10.4103/jispcd.JISPCD_70_20 [doi] AB - OBJECTIVES: The aim of this study was to describe the attitude and perception toward antiplatelet/anticoagulant agents in patients with cardiovascular diseases among dentists in the northern district of Jordan and to compare the current practice of Jordanian dentists and the recently published guidelines regarding the management of patients taking antiplatelet/anticoagulant drugs before dental procedures. MATERIALS AND METHODS: This is a cross-sectional study conducted on dentists and dental interns working at the dental clinics in northern Jordan, including dental clinics at Jordan University of Science and Technology (JUST) and the private sector. The total sample size comprised of 128 subjects (78 dentists from JUST and 50 private practitioners). The participants were interviewed using a preformed questionnaire to assess their knowledge and perceptions regarding the antiplatelets and the anticoagulant agents. RESULTS: Approximately 61.5% of participants from JUST university and 20.0% of those in the private sector were aware of the use of clopidogrel (P < 0.0001). Although the overall awareness regarding other antiplatelets such as prasugrel was very low (8.6%), dentists from JUST (12.8%) showed a significantly higher level of awareness compared to the private practitioners (2.0%) (P = 0.049). More than 70% of the participants from JUST and only 46.0% of the private practitioners were aware of the consequences of interrupting treatment with clopidogrel in patients with coronary stents (P = 0.002). Almost both the participants from JUST (25.78%) and the private sector (24.22%) are consulting the cardiologists with similar frequencies before interrupting the treatment with the antiplatelet/anticoagulant agents. Participants who have clinical PhD qualifications are more aware of the recent clinical guidelines and the newest agents compared to others. CONCLUSIONS: The awareness regarding the newest antiplatelet/anticoagulant agents is poor among the dentists in northern Jordan. However, the majority (62.3%) of them realize the consequences of interrupting such treatments in patients with coronary stents. Unfortunately, only a quarter of the dentists are consulting the cardiologists before interrupting the treatment with the antiplatelet agents. Proper education, courses, and workshops should be performed to the dentists to improve their knowledge about this critical issue. CI - Copyright: (c) 2020 Journal of International Society of Preventive and Community Dentistry. FAU - Ibdah, Rasheed K AU - Ibdah RK AD - Division of Cardiology, Department of Internal Medicine, Jordan University for Science and Technology, Irbid, Jordan. FAU - Rawashdeh, Sukaina I AU - Rawashdeh SI AD - Division of Cardiology, Department of Internal Medicine, Jordan University for Science and Technology, Irbid, Jordan. FAU - Harahsheh, Ehab AU - Harahsheh E AD - Department of Neurology, Mayo Clinic College of Medicine, Arizona, USA. FAU - Almegdadi, Abdallah AU - Almegdadi A AD - Division of Cardiology, Department of Internal Medicine, Jordan University for Science and Technology, Irbid, Jordan. FAU - Al Ksassbeh, Abdullah AU - Al Ksassbeh A AD - Division of Cardiology, Department of Internal Medicine, Jordan University for Science and Technology, Irbid, Jordan. FAU - Alrabadi, Nasr AU - Alrabadi N AD - Department of Pharmacology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan. LA - eng PT - Journal Article DEP - 20200928 PL - India TA - J Int Soc Prev Community Dent JT - Journal of International Society of Preventive & Community Dentistry JID - 101618802 PMC - PMC7685271 OTO - NOTNLM OT - Anticoagulants OT - antiplatelets OT - coronary stents OT - dental procedures OT - ischemic heart disease COIS- There are no conflicts of interest. EDAT- 2020/12/08 06:00 MHDA- 2020/12/08 06:01 PMCR- 2020/09/28 CRDT- 2020/12/07 05:35 PHST- 2020/02/14 00:00 [received] PHST- 2020/06/15 00:00 [revised] PHST- 2020/07/02 00:00 [accepted] PHST- 2020/12/07 05:35 [entrez] PHST- 2020/12/08 06:00 [pubmed] PHST- 2020/12/08 06:01 [medline] PHST- 2020/09/28 00:00 [pmc-release] AID - JISPCD-10-597 [pii] AID - 10.4103/jispcd.JISPCD_70_20 [doi] PST - epublish SO - J Int Soc Prev Community Dent. 2020 Sep 28;10(5):597-604. doi: 10.4103/jispcd.JISPCD_70_20. eCollection 2020 Sep-Oct.